Cook Brandoch D, Dynek Jasmin N, Chang William, Shostak Grigoriy, Smith Susan
The Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, USA.
Mol Cell Biol. 2002 Jan;22(1):332-42. doi: 10.1128/MCB.22.1.332-342.2002.
Telomere maintenance is essential for the continuous growth of tumor cells. In most human tumors telomeres are maintained by telomerase, a specialized reverse transcriptase. Tankyrase 1, a human telomeric poly(ADP-ribose) polymerase (PARP), positively regulates telomere length through its interaction with TRF1, a telomeric DNA-binding protein. Tankyrase 1 ADP-ribosylates TRF1, inhibiting its binding to telomeric DNA. Overexpression of tankyrase 1 in the nucleus promotes telomere elongation, suggesting that tankyrase 1 regulates access of telomerase to the telomeric complex. The recent identification of a closely related homolog of tankyrase 1, tankyrase 2, opens the possibility for a second PARP at telomeres. We therefore sought to establish the role of tankyrase 1 at telomeres and to determine if tankyrase 2 might have a telomeric function. We show that endogenous tankyrase 1 is a component of the human telomeric complex. We demonstrate that telomere elongation by tankyrase 1 requires the catalytic activity of the PARP domain and does not occur in telomerase-negative primary human cells. To investigate a potential role for tankyrase 2 at telomeres, recombinant tankyrase 2 was subjected to an in vitro PARP assay. Tankyrase 2 poly(ADP-ribosyl)ated itself and TRF1. Overexpression of tankyrase 2 in the nucleus released endogenous TRF1 from telomeres. These findings establish tankyrase 2 as a bona fide PARP, with itself and TRF1 as acceptors of ADP-ribosylation, and suggest the possibility of a role for tankyrase 2 at telomeres.
端粒维持对于肿瘤细胞的持续生长至关重要。在大多数人类肿瘤中,端粒由端粒酶(一种特殊的逆转录酶)维持。端锚聚合酶1是一种人类端粒多聚(ADP-核糖)聚合酶(PARP),通过与端粒DNA结合蛋白TRF1相互作用来正向调节端粒长度。端锚聚合酶1使TRF1发生ADP-核糖基化,抑制其与端粒DNA的结合。端锚聚合酶1在细胞核中的过表达促进端粒延长,这表明端锚聚合酶1调节端粒酶与端粒复合物的结合。最近发现了与端锚聚合酶1密切相关的同源物端锚聚合酶2,这为端粒上存在第二种PARP提供了可能性。因此,我们试图确定端锚聚合酶1在端粒中的作用,并确定端锚聚合酶2是否可能具有端粒功能。我们发现内源性端锚聚合酶1是人类端粒复合物的一个组成部分。我们证明,端锚聚合酶1介导的端粒延长需要PARP结构域的催化活性,并且在端粒酶阴性的原代人类细胞中不会发生。为了研究端锚聚合酶2在端粒中的潜在作用,对重组端锚聚合酶2进行了体外PARP测定。端锚聚合酶2使自身和TRF1发生多聚(ADP-核糖)化。端锚聚合酶2在细胞核中的过表达使内源性TRF1从端粒上释放出来。这些发现确定端锚聚合酶2是一种真正的PARP,自身和TRF1是ADP-核糖基化的受体,并提示端锚聚合酶2在端粒中发挥作用的可能性。